SEC Comment Letter for BNB PLUS CORP. (BNBX) (CIK 0000744452) (BNBX) — Mar 12, 2014
BNB PLUS CORP. (BNBX) (CIK 0000744452)
Date: March 12, 2014 · CIK: 0000744452 · Accession: 0000000000-14-012466
AI Filing Summary & Sentiment
Reasoning
Referenced dates: February 20, 2014
Letter
March 12 , 2014 Via E -mail Mr. James A. Hayward Chief Executive Officer Applied DNA Sciences, Inc. 50 Health Sciences Drive Stony Brook, NY 11790
Re: Applied DNA Sciences, Inc. Form 10-K for the Year Ended September 30, 2013 Filed December 20, 2013 Response Dated March 5, 2014 File No. 2 -90539
Dear Mr. Hayward :
We have reviewed your response dated March 5, 2014 and have the following comment . In our comment , we may ask you to provide us with information so we may better understand your disclosure.
Please respond to this letter within ten business days by providing the requested information, or by advising us when you will provide the requested response. If you do not believe our comment applies to your facts and circumstances, please tell us why in your response.
After reviewing the information you provide in response to this comment , we may have additional comments.
Item 1. Business, page 1
Present Markets, page 6
1. We note your response to comment one in our letter dated February 20, 2014. In future filings, for each listed Present Market, please clarify if you are currently selling your products in that market or if you plan to do so in the near future. Fo r example, we note your statement under “Textiles and Apparel” that your SigNature T DNA and fiberTyping solutions “could have significant potential applications” in this market. Similarly much of your disclosure says that your SigNature DNA “can provide” services in the markets discussed, which makes it unclear if your products are currently in use in such markets. If you have not made any sales in a particular market, please move that respective discussion to Future Markets. In addition, please clarify whether your products are used by the agencies and companies discussed in this section. As currently
James A. Hayward Applied DNA Sciences, Inc. March 12 , 2014 Page 2
drafted, it is unclear if you are citing certain agencies or companies just to provide an overview of each market and the needs in each market, or if the se agencies and companies a ctually use your p roducts.
You may contact David Korvin, Staff Attor ney, at (202) 551 -3236 or Erin Jaskot, Staff Attorney, at (202) 551 -3442 if you have questions regarding this comment .
Sincerely,
/s/ John Cash
Show Raw Text
March 12 , 2014 Via E -mail Mr. James A. Hayward Chief Executive Officer Applied DNA Sciences, Inc. 50 Health Sciences Drive Stony Brook, NY 11790 Re: Applied DNA Sciences, Inc. Form 10-K for the Year Ended September 30, 2013 Filed December 20, 2013 Response Dated March 5, 2014 File No. 2 -90539 Dear Mr. Hayward : We have reviewed your response dated March 5, 2014 and have the following comment . In our comment , we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter within ten business days by providing the requested information, or by advising us when you will provide the requested response. If you do not believe our comment applies to your facts and circumstances, please tell us why in your response. After reviewing the information you provide in response to this comment , we may have additional comments. Item 1. Business, page 1 Present Markets, page 6 1. We note your response to comment one in our letter dated February 20, 2014. In future filings, for each listed Present Market, please clarify if you are currently selling your products in that market or if you plan to do so in the near future. Fo r example, we note your statement under “Textiles and Apparel” that your SigNature T DNA and fiberTyping solutions “could have significant potential applications” in this market. Similarly much of your disclosure says that your SigNature DNA “can provide” services in the markets discussed, which makes it unclear if your products are currently in use in such markets. If you have not made any sales in a particular market, please move that respective discussion to Future Markets. In addition, please clarify whether your products are used by the agencies and companies discussed in this section. As currently James A. Hayward Applied DNA Sciences, Inc. March 12 , 2014 Page 2 drafted, it is unclear if you are citing certain agencies or companies just to provide an overview of each market and the needs in each market, or if the se agencies and companies a ctually use your p roducts. You may contact David Korvin, Staff Attor ney, at (202) 551 -3236 or Erin Jaskot, Staff Attorney, at (202) 551 -3442 if you have questions regarding this comment . Sincerely, /s/ John Cash John Cash Accounting Branch Chief